21-46228755-A-T
Position:
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_002340.6(LSS):c.-10T>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00037 in 1,588,256 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (no stars).
Frequency
Genomes: 𝑓 0.00027 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00038 ( 4 hom. )
Consequence
LSS
NM_002340.6 5_prime_UTR
NM_002340.6 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.23
Genes affected
LSS (HGNC:6708): (lanosterol synthase) The protein encoded by this gene catalyzes the conversion of (S)-2,3 oxidosqualene to lanosterol. The encoded protein is a member of the terpene cyclase/mutase family and catalyzes the first step in the biosynthesis of cholesterol, steroid hormones, and vitamin D. Alternative splicing results in multiple transcript variants encoding different isoforms.[provided by RefSeq, Feb 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -13 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant 21-46228755-A-T is Benign according to our data. Variant chr21-46228755-A-T is described in ClinVar as [Likely_benign]. Clinvar id is 3054304.Status of the report is no_assertion_criteria_provided, 0 stars.
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.000271 (40/147764) while in subpopulation SAS AF= 0.00364 (17/4674). AF 95% confidence interval is 0.00232. There are 0 homozygotes in gnomad4. There are 26 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 4 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LSS | NM_002340.6 | c.-10T>A | 5_prime_UTR_variant | 1/22 | ENST00000397728.8 | NP_002331.3 | ||
LSS | NM_001001438.3 | c.-10T>A | 5_prime_UTR_variant | 1/23 | NP_001001438.1 | |||
LSS | NM_001145436.2 | c.-10T>A | 5_prime_UTR_variant | 1/22 | NP_001138908.1 | |||
LSS | NM_001145437.2 | c.-382T>A | 5_prime_UTR_variant | 1/21 | NP_001138909.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LSS | ENST00000397728.8 | c.-10T>A | 5_prime_UTR_variant | 1/22 | 1 | NM_002340.6 | ENSP00000380837.2 |
Frequencies
GnomAD3 genomes AF: 0.000271 AC: 40AN: 147646Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
40
AN:
147646
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000727 AC: 157AN: 215834Hom.: 2 AF XY: 0.000919 AC XY: 110AN XY: 119636
GnomAD3 exomes
AF:
AC:
157
AN:
215834
Hom.:
AF XY:
AC XY:
110
AN XY:
119636
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000380 AC: 547AN: 1440492Hom.: 4 Cov.: 33 AF XY: 0.000512 AC XY: 367AN XY: 716784
GnomAD4 exome
AF:
AC:
547
AN:
1440492
Hom.:
Cov.:
33
AF XY:
AC XY:
367
AN XY:
716784
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000271 AC: 40AN: 147764Hom.: 0 Cov.: 32 AF XY: 0.000360 AC XY: 26AN XY: 72138
GnomAD4 genome
AF:
AC:
40
AN:
147764
Hom.:
Cov.:
32
AF XY:
AC XY:
26
AN XY:
72138
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
7
AN:
3472
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
LSS-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 09, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at